| - IKF/AIO-QUINTIS - Evaluating Fruquintinib in Combination With Tislelizumab in Microsatellite S | Phase II | rekrutiert |
| A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Scle | — | rekrutiert |
| A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor f | — | rekrutiert |
| A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Sa | Phase III | rekrutiert |
| A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Even | Phase III | rekrutiert |
| A Phase-3-trial of Acalabrutinib, Obinutuzumab & Venetoclax Compared to Obinutuzumab and Venetoc | Phase III | rekrutiert |
| A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With A | — | rekrutiert |
| A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab a | Phase III | rekrutiert |
| A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Do | Phase III | rekrutiert |
| A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D | Phase II | rekrutiert |
| A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or | Phase III | rekrutiert |
| A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) | Phase III | rekrutiert |
| A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthriti | Phase III | rekrutiert |
| A Study of Real-Life Current Standards of Care in Participants With Relapsed and/or Refractory M | — | rekrutiert |
| A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tra | Phase III | rekrutiert |
| A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Pati | Phase III | rekrutiert |
| A Study of Trastuzumab DeRuxtecan for Patients With Advanced HER2-pOsitive GaStric or GastroesoP | — | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard | Phase II | rekrutiert |
| A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Adults Wit | Phase III | rekrutiert |
| A Study to Investigate Mechanisms of Resistance to Breast Cancer Therapies | Phase IV | rekrutiert |
| AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Exc | Phase III | rekrutiert |
| AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Exc | Phase III | rekrutiert |
| AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate | Phase III | rekrutiert |
| Ablation of Consecutive Atrial Tachycardia | ohne Phasenangabe | rekrutiert |
| Acalabrutinib in Combination With R-miniCHOP in Older Adults With Untreated Diffuse Large B-Cell | Phase III | rekrutiert |
| Adjusted High-dose Chemotherapy With Autologous Stem Cell Transplant vs. Conventional Immunochem | Phase III | rekrutiert |
| Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipopr | Phase III | rekrutiert |
| Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment | — | rekrutiert |
| Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintena | Phase III | rekrutiert |
| Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD | Phase III | rekrutiert |
| Cohort Study on Plant-based Diets (COPLANT Study) | — | rekrutiert |
| Combination of Abemaciclib and Endocrine Therapy in Hormone Receptor Positive HER2 Negative Loca | Phase IV | rekrutiert |
| Combining Loncastuximab Tesirine and Epcoritamab in Relapsed/Refractory Diffuse Large B-cell Lym | Phase II | rekrutiert |
| Complete Revascularization Versus Culprit Lesion Only PCI in NSTEMI | ohne Phasenangabe | rekrutiert |
| Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Re | Phase IV | rekrutiert |
| Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain an | Phase III | rekrutiert |
| Endometrial Cancer Lymphadenectomy Trial | ohne Phasenangabe | rekrutiert |
| Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia | Phase III | rekrutiert |
| FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab i | Phase II / Phase III | rekrutiert |
| GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, T | — | rekrutiert |
| International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lym | Phase III | rekrutiert |
| International HIT-MED Registry (I-HIT-MED) | — | rekrutiert |
| Ivosidenib and Azacitidine With or Without Venetoclax in Adult Patients With Newly Diagnosed IDH | Phase III | rekrutiert |
| Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on | Phase III | rekrutiert |
| Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Pos | Phase III | rekrutiert |
| Multicenter Study for Diagnostic Validation of a Laboratory Test for the Diagnosis of Endometrio | — | rekrutiert |
| Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in A | Phase III | rekrutiert |
| OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cance | Phase III | rekrutiert |
| PROCARE - PROstate Cancer Real World Evidence Registry | — | rekrutiert |
| PROOFS-Registry - Premenopausal Women With Breast Cancer Optimally Treated With OFS | — | rekrutiert |
| PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and | — | rekrutiert |
| Phase III Randomized International Open Label Clinical Trial of Treatment Intensification With D | Phase III | rekrutiert |
| Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With New | Phase III | rekrutiert |
| Post-market Clinical Investigation of the SING IMT System, Model NG SI IMT 3X in Patients With E | ohne Phasenangabe | rekrutiert |
| Praegnant Breast Cancer: Early/Advanced/Metastatic | — | rekrutiert |
| Prevention Of Sudden Cardiac Death After Myocardial Infarction by Defibrillator Implantation | ohne Phasenangabe | rekrutiert |
| Product Surveillance Registry | — | rekrutiert |
| Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blin | Phase II | rekrutiert |
| Real-world Effectiveness Study of Long-term Treatment With Dupilumab in Participants ≥6 Years Wi | — | rekrutiert |
| Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis | — | rekrutiert |
| Real-world Experience on Using Nemolizumab in the Treatment of Moderate-to- Severe Prurigo Nodul | — | rekrutiert |
| Registry Study on Patient Characteristics, Biological Disease Profile and Clinical Outcome in Ac | — | rekrutiert |
| Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearran | Phase III | rekrutiert |
| Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available The | Phase III | rekrutiert |
| Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in | Phase III | rekrutiert |
| Study to Assess Change in Disease Activity of Risankizumab Treatment in Adult Participants With | — | rekrutiert |
| Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS | ohne Phasenangabe | rekrutiert |
| The Fourth Left Atrial Appendage Occlusion Study | ohne Phasenangabe | rekrutiert |
| Therapy Optimisation for the Treatment of Hairy Cell Leukemia | Phase II / Phase III | rekrutiert |
| Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM AL | Phase III | rekrutiert |